Ritonavir protects against the development of atherosclerosis in APOE *3-Leiden mice

The Netherlands twin register biobank: A resource for genetic epidemiological studies

CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice

Fenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE*3-Leiden.CETP mice

Effect of plasma triglyceride metabolism on lipid storage in adipose tissue: Studies using genetically engineered mouse models

PXR agonism decreases plasma HDL levels in ApoE*3-Leiden.CETP mice

The expression of type III hyperlipoproteinemia: Involvement of lipolysis genes

Human CETP aggravates atherosclerosis by increasing VLDL-cholesterol rather than by decreasing HDL-cholesterol in APOE*3-Leiden mice

CNTO736, a novel glucagon-like peptide-1 receptor agonist, ameliorates insulin resistance and inhibits very low-density lipoprotein production in high-fat-fed mice

Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone

LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: Time course and mechanisms

Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size

The association of 83 plasma proteins with CHD mortality, BMI, HDL-, and total-cholesterol in men: Applying multivariate statistics to identify proteins with prognostic value and biological relevance

The dual PPARα/γ agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice

Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo

Plasma apolipoprotein CI protects against mortality from infection in old age

Moderate alcohol consumption and lipoprotein-associated phospholipase A2 activity

The impact of metabolic syndrome and CRP on vascular phenotype in type 2 diabetes mellitus

Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: Investigating differential effects among statins

Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice